FDA October 14, 2021 5:13 pm

FDA Panel Endorses Lower-Dose Booster Moderna COVID Shots for Seniors, High Risk

U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus.

Wake Up to Something Good

1:57

Woman shares lifelong battle with diabetes and overcoming depression
1:59

Toothpaste for peanut allergies?
2:16

North Texas medical graduate donates to leukemia patient
2:30

Garland firefighter shares lesson after surviving stroke
2:13

$100 million gift will go toward new Dallas pediatric hospital campus
Exit mobile version